Back
Theravance Biopharma Quote, Financials, Valuation and Earnings
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
47
TBPH
Theravance Biopharma
Last Price:
8.23
Seasonality Move:
11.3%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeTheravance Biopharma Price Quote
$8.23
+0.01 (+-0.6%)
(Updated: November 5, 2024 at 4:18 AM ET)
Theravance Biopharma Key Stats
Sell
47
Theravance Biopharma (TBPH)
is a Sell
Day range:
$8.21 - $8.31
52-week range:
$7.44 - $11.71
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.59
P/B ratio:
2.08%
Volume:
80.1K
Avg. volume:
157.5K
1-year change:
-16.55%
Market cap:
$402.1M
Revenue:
$57.4M
EPS:
$-0.92
How Much Does Theravance Biopharma Make?
-
How Much Are Theravance Biopharma's Sales Annually?
TBPH Revenues are $57.4M -
How Much Profit Does Theravance Biopharma's Make A Year?
TBPH net income is -$55.2M
Is Theravance Biopharma Growing As A Company?
-
What Is Theravance Biopharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.04% -
What Is Theravance Biopharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Theravance Biopharma Stock Price Performance
-
Did Theravance Biopharma Stock Go Up Last Month?
Theravance Biopharma share price went up by 1.48% last month -
Did TBPH's Share Price Rise Over The Last Year?
TBPH share price fell by -16.55% over the past 1 year
What Is Theravance Biopharma 52-Week High & Low?
-
What Is Theravance Biopharma’s 52-Week High Share Price?
Theravance Biopharma has traded as high as $11.71 over the past 52 weeks -
What Is Theravance Biopharma’s 52-Week Low Share Price?
Theravance Biopharma has traded as low as $7.44 over the past 52 weeks
Theravance Biopharma Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Theravance Biopharma?
-
How Much Debt Does Theravance Biopharma Have?
Total long term debt quarterly is $0 -
How Much Cash Does Theravance Biopharma Have?
Cash and short term investments quarterly total is $96.1M -
What Is Theravance Biopharma’s Book Value Per Share?
Book value per share is 3.96
Is Theravance Biopharma Cash Flow Positive?
-
What Is TBPH Cash Flow From Operations?
Cash flow from operations (TTM) is -$8.8M -
What Is Theravance Biopharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$63.8M -
What Is Theravance Biopharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is $13.3M
Theravance Biopharma Return On Invested Capital
-
Is Management Doing A Good Job?
TBPH return on invested capital is -20.06% -
What Is Theravance Biopharma Return On Assets?
ROA measures how assets are converting to revenues and is -11.56% -
What Is TBPH Return On Equity?
ROE is a measure of profitability and is -20.06%
Theravance Biopharma Earnings Date & Stock Price
-
What Is Theravance Biopharma's Stock Price Today?
A single share of TBPH can be purchased today for 8.22 -
What Is Theravance Biopharma’s Stock Symbol?
Theravance Biopharma trades on the nasdaq under the ticker symbol: TBPH -
When Is Theravance Biopharma’s Next Earnings Date?
The next quarterly earnings date for Theravance Biopharma is scheduled on November 12, 2024 -
When Is TBPH's next ex-dividend date?
Theravance Biopharma's next ex-dividend date is November 5, 2024 -
How To Buy Theravance Biopharma Stock?
You can buy Theravance Biopharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Theravance Biopharma Competitors
-
Who Are Theravance Biopharma's Competitors?
Below is a list of companies who compete with Theravance Biopharma or are related in some way:
Theravance Biopharma Dividend Yield
-
What Is TBPH Dividend Yield?
Theravance Biopharma’s dividend yield currently is 0% -
What Is Theravance Biopharma’s Payout Ratio?
Theravance Biopharma’s payout ratio is 0% -
When Did Theravance Biopharma Last Pay A Dividend?
The latest dividend pay date is November 5, 2024 -
What Is Theravance Biopharma’s Dividend Per Share?
Theravance Biopharma pays a dividend of $0.00 per share
Theravance Biopharma Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -85.71% |
| Revenue: | 3.69% | -6.87% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 3 |
| Sell Recommendations: | 0 |
| Price Target: | 13.20 |
| Upside from Last Price: | 60.58% |